Ultralife (NASDAQ:ULBI) Receives “Buy” Rating from Benchmark

Benchmark reiterated their buy rating on shares of Ultralife (NASDAQ:ULBIFree Report) in a report released on Friday morning,Benzinga reports. Benchmark currently has a $14.00 target price on the technology company’s stock.

Separately, StockNews.com downgraded shares of Ultralife from a “strong-buy” rating to a “buy” rating in a research note on Thursday, October 3rd.

Get Our Latest Report on Ultralife

Ultralife Price Performance

Shares of ULBI opened at $7.54 on Friday. The company has a market cap of $125.39 million, a price-to-earnings ratio of 13.71 and a beta of 0.98. Ultralife has a twelve month low of $6.36 and a twelve month high of $13.39. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The company has a 50 day moving average of $8.94 and a two-hundred day moving average of $10.20.

Institutional Trading of Ultralife

Several institutional investors have recently modified their holdings of the stock. O Shaughnessy Asset Management LLC acquired a new position in Ultralife during the first quarter worth about $100,000. Barclays PLC boosted its position in Ultralife by 21.3% during the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock worth $121,000 after acquiring an additional 2,355 shares during the last quarter. Rhumbline Advisers boosted its holdings in Ultralife by 1,728.3% in the 2nd quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock valued at $125,000 after purchasing an additional 11,165 shares during the last quarter. Perritt Capital Management Inc. boosted its holdings in Ultralife by 25.0% in the 1st quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Juncture Wealth Strategies LLC acquired a new position in Ultralife in the 3rd quarter valued at about $165,000. Institutional investors and hedge funds own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

Featured Articles

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.